Marked Variation in Paediatric Problematic Severe Asthma Services Across Australia and New Zealand
Journal of Paediatrics and Child Health · 2025
DOI: 10.1111/jpc.70190 ↗At a glance
Beobachtungsstudie in Journal of Paediatrics and Child Health, 2025. Written by Ajay Kevat and 15 co-authors. Institution: Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, Australia. Major MEDLINE topics: Asthma. 29 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Novartis Australia.
Abstract (original language)
Aims
Asthma affects > 10% of children in Australia and New Zealand (NZ), with up to 5% of those having severe disease, presenting a management challenge. We aimed to survey tertiary paediatric respiratory services across Australia and NZ using a custom‐designed questionnaire, to conduct a cross‐sectional observational study of the numbers of children with problematic severe asthma (PSA) seen, the number treated with biologic therapy, outpatient clinic/multidisciplinary team (MDT) services available, investigations and tools routinely used and approaches utilised for transition to adult care.
Methods
A custom‐designed online survey was distributed via email to Directors of public paediatric respiratory services across Australia and NZ ( n = 14). Reminders to prompt completion were emailed regularly over 3 months.
Results
All sites provided survey responses. The estimated number of children with PSA across 12 sites was 561 (53 prescribed biologic treatment); two sites felt unable to provide accurate estimations. Most sites ( n = 8) did not have a MDT approach either as MDT clinics or meetings; patients were managed in either asthma ( n = 7, 50%) or general respiratory clinics. Most sites (85%) utilised questionnaires regarding asthma control for assessment, although some utilised additional questionnaires. Remaining tools and investigations varied widely across centres. Only four sites (29%) had established processes for transition to adult care.
Conclusions
Given notable heterogeneity in service availability and PSA management across tertiary sites, children may experience variability in care dependent on their location. Most centres lack MDT models of care, which are considered the international best‐practise standard for management of children with PSA.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, Australia.
- Faculty of Medicine, University of Queensland, Brisbane, Australia.
- Department of Paediatrics, Waitaha Canterbury, Health New Zealand Te Whatu Ora, New Zealand.
- Paediatric Respiratory Department, John Hunter Children's Hospital, New Lambton Heights, New South Wales, Australia.
- Kids Cancer Centre, Sydney Children's Hospital Randwick, Sydney, Australia.
- University of Queensland Medical School, Brisbane, Australia.
ORCID profiles: Ajay Kevat, Shivanthan Shanhikumar
Funding
- Novartis Australia
Cite
APA
Kevat, A., Dalton, S., Goddard, B., Mitchell, L., Graham, E., Owens, L., Goddard, T., Gray, M., Haggie, S., Laing, I., Mulholland, A., Oo, S., Roseby, R., Singh, J., Shanhikumar, S., & Robinson, P. D. (2025). Marked Variation in Paediatric Problematic Severe Asthma Services Across Australia and New Zealand. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.70190
Vancouver
Kevat A, Dalton S, Goddard B, Mitchell L, Graham E, Owens L, et al. Marked Variation in Paediatric Problematic Severe Asthma Services Across Australia and New Zealand. Journal of Paediatrics and Child Health. 2025. doi:10.1111/jpc.70190
BibTeX
@article{Kevat2025,
author = {Kevat, Ajay and Dalton, Samuel and Goddard, Bernadette and Mitchell, Laura and Graham, Eloise and Owens, Louisa and Goddard, Tom and Gray, Melinda and Haggie, Stuart and Laing, Ingrid and Mulholland, Anna and Oo, Stephen and Roseby, Robert and Singh, Jagdev and Shanhikumar, Shivanthan and Robinson, Paul D},
title = {Marked Variation in Paediatric Problematic Severe Asthma Services Across Australia and New Zealand},
journal = {Journal of Paediatrics and Child Health},
year = {2025},
doi = {10.1111/jpc.70190}
}
EUVIMED